Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank43
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-52.54M
↓ 235% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$38.81M
Historical baseline
PeriodValueYoY Change
TTM$-52.54M+18.5%
2024$-64.43M+13.3%
2023$-74.30M-36.3%
2022$-54.51M-14.8%
2021$-47.47M-257.7%
2020$-13.27M-38.8%
2019$-9.56M-101.5%
2018$626.60M-